prolyl hydroxylase domain-containing protein 2 inhibitors (University of Pennsylvania/FCCDC)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprolyl hydroxylase domain-containing protein 2 inhibitors (University of Pennsylvania/FCCDC)
Drug Alias NamePHD2 inhibitors (University of Pennsylvania/FCCDC)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProlyl hydroxylase domain-containing protein 2 inhibitors
TargetsProlyl hydroxylase domain-containing protein 2
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of PennsylvaniaFox Chase Chemical Diversity Center Inc
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A